These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy. Regula JU; Jestaedt L; Jende F; Bartsch A; Meinck HM; Weber MA Clin Neuroradiol; 2016 Dec; 26(4):445-455. PubMed ID: 25860436 [TBL] [Abstract][Full Text] [Related]
7. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338 [TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4. Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919 [TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis of facioscapulohumeral muscular dystrophy. Upadhyaya M; Cooper DN Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336 [TBL] [Abstract][Full Text] [Related]
10. Winged scapula in patients with myotonic dystrophy type 1. Hamano T; Mutoh T; Hirayama M; Uematsu H; Higuchi I; Koga H; Umehara F; Komai K; Kuriyama M Neuromuscul Disord; 2012 Aug; 22(8):755-8. PubMed ID: 22683376 [TBL] [Abstract][Full Text] [Related]
11. Characteristic MRI Findings of upper Limb Muscle Involvement in Myotonic Dystrophy Type 1. Sugie K; Sugie M; Taoka T; Tonomura Y; Kumazawa A; Izumi T; Kichikawa K; Ueno S PLoS One; 2015; 10(4):e0125051. PubMed ID: 25919300 [TBL] [Abstract][Full Text] [Related]
12. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations. Voermans NC; van der Bilt RC; IJspeert J; Hogrel JY; Jeanpierre M; Behin A; Laforet P; Stojkovic T; van Engelen BG; Padberg GW; Sacconi S; Lemmers RJLF; van der Maarel SM; Eymard B; Bassez G J Neurol; 2019 Dec; 266(12):2987-2996. PubMed ID: 31471688 [TBL] [Abstract][Full Text] [Related]
13. Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011. Attarian S; Salort-Campana E; Nguyen K; Behin A; Andoni Urtizberea J Rev Neurol (Paris); 2012 Dec; 168(12):910-8. PubMed ID: 22551571 [TBL] [Abstract][Full Text] [Related]
14. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers. Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911 [TBL] [Abstract][Full Text] [Related]
15. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1. Thornell LE; Lindstöm M; Renault V; Klein A; Mouly V; Ansved T; Butler-Browne G; Furling D Neuropathol Appl Neurobiol; 2009 Dec; 35(6):603-13. PubMed ID: 19207265 [TBL] [Abstract][Full Text] [Related]
16. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1. Kaliman P; Llagostera E Cell Signal; 2008 Nov; 20(11):1935-41. PubMed ID: 18583094 [TBL] [Abstract][Full Text] [Related]
17. Atypical progression of motor symptoms in facio-scapulo-humeral dystrophy: clinical worsening or overlap? Calisi D; De Rosa MA; Russo M; Sensi SL BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37247956 [TBL] [Abstract][Full Text] [Related]
18. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1. Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448 [TBL] [Abstract][Full Text] [Related]